KLK3 and prostate cancer: In 2004, Ohyama et al. demonstrated that free serum PSA from patients with prostate cancer exhibits increased binding to Maackia amurensis agglutinin (MAA) lectin, which recognizes α2,3-linked sialic acid, compared with that in patients with BPH [83].